Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SLC2A4 regulator | 0.615 | 0.692 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
acid sensing ion channel subunit family member 4 | 0.769 | 0.115 | 2.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
latent transforming growth factor beta binding protein 4 | 0.604 | 0.654 | 0.50 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
Ral GEF with PH domain and SH3 binding motif 2 | 0.805 | 0.154 | 0.26 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
vertebrae development associated | 1.000 | 0.077 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
forkhead box P1 | 0.460 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
fibroblast growth factor 10 | 0.530 | 0.692 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
growth differentiation factor 5 | 0.511 | 0.692 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
STN1 subunit of CST complex | 0.604 | 0.769 | 2.3E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
ITFG2 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | |||||||||||
|
ATPase family AAA domain containing 5 | 0.711 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat and fibronectin type III domain containing 1 | 0.890 | 0.154 | 2.1E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
KIAA2012 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
BCL2 family apoptosis regulator BOK | 0.722 | 0.346 | 0.16 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
nephronectin | 0.659 | 0.654 | 2.7E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | ||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
calcium and integrin binding family member 4 | 1.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||||
|
calcium/calmodulin dependent protein kinase II gamma | 0.670 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
disrupted in renal carcinoma 3 | 0.780 | 0.308 | 3.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
microtubule associated monooxygenase, calponin and LIM domain containing 3 | 0.792 | 0.269 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
ataxin 3 | 0.521 | 0.808 | 0.11 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
Bcl2 modifying factor | 0.663 | 0.423 | 6.8E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 |